Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women

Simple item page
dc.contributor.authorMurnane, Pamela M.
dc.contributor.authorBacchetti, Peter
dc.contributor.authorCurrier, Judith S.
dc.contributor.authorBrummel, Sean
dc.contributor.authorOkochi, Hideaki
dc.contributor.authorPhung, Nhi
dc.contributor.authorLouie, Alexander
dc.contributor.authorKuncze, Karen
dc.contributor.authorHoffman, Risa M.
dc.contributor.authorNematadzira, Teacler
dc.contributor.authorSoko, Dean K.
dc.contributor.authorOwor, Maxensia
dc.contributor.authorSaidi, Friday
dc.contributor.authorFlynn, Patricia M.
dc.contributor.authorGlenn Fowler, Mary
dc.contributor.authorGandhi, Monica
dc.date.accessioned2022-03-08T11:43:48Z
dc.date.available2022-03-08T11:43:48Z
dc.date.issued2019
dc.description.abstractAntiretroviral treatment (ART) adherence is often suboptimal in the perinatal period. We measured hair tenofovir (TFV) concentrations as a metric of adherence in postpartum women to understand patterns and predictors of adherence throughout this critical period. Additionally, we examined the association between hair TFV concentrations and virologic outcomes. Methods: Between 12/2012–09/2016, hair samples were collected longitudinally from delivery through breastfeeding from women on ART in the PROMISE study (NCT01061151) in sub-Saharan Africa. Hair TFV levels were measured using validated methods. Using generalized estimating equations, we estimated the association between hair TFV levels and virologic suppression (<400 copies/mL) over time and assessed predictors of hair TFV levels. Results: Hair TFV levels were measured at 370 visits in 71 women from delivery through a median of 14 months (IQR 12–15) of breastfeeding. Levels ranged from below detection (0.002) to 1.067 nanograms/milligram (geometric mean: 0.047). After ≥90 days on ART, 69 women had at least one viral load measured (median 5 measures, range 1–9); 18 (26%) experienced viremia at least once. Each doubling of TFV level more than doubled odds of concurrent virologic suppression (OR 2.35, 95%CI: 1.44–3.84, p=0.0006) and was associated with 1.43 times the odds of future suppression (95%CI: 0.75–2.73, p=0.28). Relative to the first 3 months after delivery, hair levels were highest in months 6–12 (1.42 fold higher, 95%CI: 1.09–1.85, p=0.01). Conclusion: Hair TFV levels strongly predicted concurrent virologic suppression among breastfeeding women. Objective adherence metrics can supplement virologic monitoring to optimize treatment outcomes in this important transition period.en_US
dc.identifier.citationMurnane, P. M., Bacchetti, P., Currier, J. S., Brummel, S., Okochi, H., Phung, N., ... & Gandhi, M. (2019). Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS (London, England), 33(10), 1657. doi:10.1097/QAD.0000000000002237.en_US
dc.identifier.other10.1097/QAD.0000000000002237
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/2563
dc.language.isoenen_US
dc.publisherAIDS (London, England)en_US
dc.subjectHIVen_US
dc.subjectAdherenceen_US
dc.subjectPregnancyen_US
dc.subjectBreastfeedingen_US
dc.subjectViral loaden_US
dc.subjectHairen_US
dc.titleTenofovir concentrations in hair strongly predict virologic suppression in breastfeeding womenen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Tenofovir concentrations in hair strongly predict virologic.pdf
Size:
166.62 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences